← Back to Search

Dietary Supplement

Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction

N/A
Waitlist Available
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at day 56

Summary

This trial tests if a mix of maqui berry extract and omega-3 fatty acids can lower inflammation in older, obese adults. Maqui berries have special plant pigments that reduce inflammation, and omega-3s are known for their anti-inflammatory effects. Maqui berries (Aristotelia chilensis) are known for their antioxidant, anticancer, and anti-inflammatory properties.

Eligible Conditions
  • Inflammation and Pain
  • Inflammation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at day 56
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at day 56 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Interleukin-1 beta (IL-1 beta)
Interleukin-6 (IL-6)
Tumor Necrosis Factor (TNF)
Secondary study objectives
Arachidonic acid (AA)
Eicosapentaenoic acid

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Maqui berry extract and omega-3 fatty acidsExperimental Treatment1 Intervention
2 capsules BID per day containing a total of 600 mg of Maqui extract; 4 capsules per day supplying a total of 2000 mg EPA and 1000 mg DHA
Group II: ControlPlacebo Group1 Intervention
4 olive oil soft gelatin capsules and inert two-piece capsules containing maltodextrin
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Maqui berry/omeg-3 fatty acids
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
301 Previous Clinical Trials
108,018 Total Patients Enrolled

Media Library

Maqui berry/omega-3 fatty acids (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04914312 — N/A
Inflammation and Pain Research Study Groups: Maqui berry extract and omega-3 fatty acids, Control
Inflammation and Pain Clinical Trial 2023: Maqui berry/omega-3 fatty acids Highlights & Side Effects. Trial Name: NCT04914312 — N/A
Maqui berry/omega-3 fatty acids (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04914312 — N/A
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top